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1. Introduction 
A number of calcium-binding proteins have a 
domain structure and the domain primary structures 
are rather similar. Parvalbumins have three domains, 
two of them are able to bind calcium [l] . Homology 
of this kind can be found in troponin C [2] and 
myosin alkali light chains [3] having four domains. 
Similarity of the primary and spatial structures of 
calcium-binding proteins and their domains suggested 
that there was a common evolutionary ancestor of 
these proteins and that subsequently gene duplica- 
tion took place [4]. The ancestor structure was 
predicted [5] to be a 40-membered peptide with the 
following amino acid sequence :
5 
H - Glu - Gln - Thr - Asp - Asp - Glu - Ile - 
10 15 
Lys - Glu - Val - Leu - Lys - Ala - Phe - Asp - 
20 
Lys - Asp - Gly - Gly - Gly - Arg - Ile - Asp - 
25 30 
Phe - Glu - Glu - Phe - Val - Lys - Leu - Ile - 
35 
Leu - Gly - Val - Thr - Gly - Glu - Gly - Ala - 
40 
Arg - OH 
A calcium-binding peptide of this primary structure 
is unknown in nature at present, and isolation of 
the calcium-binding domain structurally corresponding 
to the ancestor failed; the isolated domain of carp 
parvalbumin was unable to bind calcium [6,8] . 
Chemical synthesis of the ancestor peptide chain 
would be a direct verification of the hypothesis. We 
have synthesized this peptide and have found that it 
possesses a specific calcium-binding activity. 
2. Materials and methods 
Pentafluorophenyl esters of amino acids were 
synthesized according to published methods [7]. 
Amino acid derivatives (Reanal, Hungary) were used 
for the synthesis. Sephadex (Pharmacia, Sweden) was 
used for purification of synthesized peptides. Purifica- 
tion of blocked peptides was carried out on Sephadex 
LH-20 in dimethylformamide. Sephadex G-25 in 
0.02 M NH4HC03, pH 8.0, and DEAE-Sephadex 
A-25 in 0.02 M NH4HC0s, pH 8.0 (KC1 gradient 
from 0.0-l .O M) were used for isolation of the 
unblocked final tetracontapeptide. Amino acid 
analysis was made with a Durrum D-500 analyzer. 
The amino acid sequence was determined with the 
automatic Beckman 890C sequencer. The N- and 
C-terminal amino acids were analyzed by standard 
methods using dansyl chloride and carboxypeptidases 
A and B, respectively. The calcium-binding ability 
was determined as in [8]. 45 CaClz (17 mCi/mg) was 
from the Radiochemical Centre Amersham (England). 
3. Results and discussion 
We synthesized the peptide of the above men- 
tioned structure using pentafluorophenyl esters of 
tert-butyloxycarbonyl amino acids. Synthesis was 
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Fig. 1. Analytical gel chromatography of the synthetic 
peptide. Column 1 X 90 cm with Sephadex G-50f. Buffer: 
50 mM Tris-HCl, pH 7.2 + 30 mM KCl; the rate was 10 ml/h. 
carried out in solution according to the general 
scheme 7 t (7 t [(5+7) -I- (7+7)]}. The fragment 
IS-26 was synthesized in collaboration with Professor 
H.-D. Jakubke (Martin-Luther-Universitat, Halle, 
DDR). 
A detailed description of the tetracontapeptide 
synthesis will be published later. After removing 
masking groups with HF/anisole the resulting peptide 
was purified by gel filtration and ion exchange 
chromatography. The analytical gel filtration showed 
that the product was homogeneous (fig.1). The syn- 
thesized tetracontapeptide had Glu as a N-terminal and 
Arg as a C-terminal amino acid, and the following 
amino acid composition (the calculated values are 
given in parentheses): 
Asp 5.13 (5) Thr 1.73” (2), Glu 6.71 (7), Gly 6.15 
(6) Ala 2.1 (2) Val 3.0 (3), Ile 3.0 (3), Leu 3.15 
(3) Phe 3.0 (3) Lys 3.92 (4) Arg 1.8 (2). 
Determination of the amino acid sequence of the 
synthesized peptide gave the following sequence for 
the N-terminal part of the peptide chain: 
5 
H - Glu - (Gln) - Thr - Asp - Asp -- Glu - Ile - 
10 15 
Lys - Glu - Val - Leu - Lys - Ala - Phe - Asp 
which coincides with the predetermined sequence. 
* Losses on hydrolysis (24 h, 6 N HCl, 110°C) were not taken 
into account 
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Fig.2. Calcium-binding ability of the synthetic peptide (A), 
that of carp parvalbumin (B) and that of fragment 76-108 of 
carp parvalbumin (C). After incubation for 30 min with 
1 mCi “‘CaCll in 0.2 ml 0.05 M Tris-HCI buffer containing 
30 mM KC1 the substance tested was loaded onto the column 
of Sephadex G-25f and eluted at the rate of 80 ml/h. Frac- 
tions of 2.5 ml were collected. 
The result of determination ofthe calcium-binding 
ability is given in tig.2. The chromatograms how that 
the synthesized peptide (in contrast to parvalbumin 
fragment 76-108 [6]) possesses a specific calcium- 
binding activity similar to that of parvalbumin. The 
ratio of the bound calcium to the quantity of the 
tested peptide in the peak (as in [8 J) indicated that 
the sample contained not more than 10% of the 
active peptide. 
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